Viralsol warning letter
This article was originally published in The Tan Sheet
Dietary supplement Viralsol is an illegally marketed drug because it is intended to cure, mitigate, treat or prevent a disease, FDA says in a recent warning letter to the Yorba Linda, Calif.-based firm. FDA takes issue with claims that the product will "halt HIV infection in human cells," "suppress recurrence" of Hepatitis A, B and C, and mitigate herpes outbreaks and West Nile virus. The company does not list Viralsol's ingredients on the website where the supplement can be purchased, but states the product has "been shown to exhibit potent antiviral properties" against influenza and hemorrhagic fever viruses...
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
INFOGRAPHIC: An interactive timeline of selected HBW Insight coverage of the growing European CBD dietary supplements market in 2020. The timeline covers the main events of a rollercoaster 12 months, including the European Commission’s indecision on whether to classify CBD as narcotic or novel food and how the path forward became clear in the UK.
Already partnering with AZ and Boehringer Ingelheim in liver targets, the UK biotech sees potential to hit ‘undruggable’ CNS targets as well.